Trends in Ophthalmic Hospital Transfers and Consultations Across US Academic Centers - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Patterns of Ophthalmology Transfers and Consultations at Academic Medical Centers in the United States

  • By

  • Shu Feng

  • Karine D. Bojikian

  • Thellea K. Leveque

  • Jacquelyn O’Banion

  • Daniel B. Moore

  • Donna H. Kim

  • Andrew T. Melson

  • Samuel J. Prater

  • Ore-ofe Adesina

  • Daniel J. Ozzello

  • Jeremy Reitinger

  • Ayaka Fujihashi

  • Joseph Bogaard

  • Theresa M. Long

  • Manasvee S. Kapadia

  • Douglas J. Rhee

  • Leona Ding

  • Jennifer T. Yu

  • October 10, 2026

Share

  • 1

    This multicenter retrospective cohort study examined ophthalmology transfers and consultations at 10 US academic medical centers over periods spanning 2013 to 2024.

  • 2

    The study assessed annual accepted and requested transfers from regional facilities and ophthalmology consultations in emergency departments and inpatient settings.

  • 3

    Consultation counts included patients transferred from outside facilities and excluded duplicate notes from the same hospital encounter.

  • 4

    Investigators normalized annual volumes by state population and hospital-specific measures, including total accepted transfers and emergency department visits.

  • 5

    Institution-specific temporal trends were evaluated with ordinary least squares regression, with autocorrelation-adjusted standard errors when serial correlation was detected.

Original Source(s)

Trends in Ophthalmic Hospital Transfers and Consultations Across US Academic Centers

  • by Shu Feng, Karine D. Bojikian, Thellea K. Leveque, Jacquelyn O’Banion, Daniel B. Moore, Donna H. Kim, Andrew T. Melson, Samuel J. Prater, Ore-ofe Adesina, Daniel J. Ozzello, Jeremy Reitinger, Ayaka Fujihashi, Joseph Bogaard, Theresa M. Long, Manasvee S. Kapadia, Douglas J. Rhee, Leona Ding, Jennifer T. Yu

  • October 10, 2026

Related Content

Repeat surgical interventions in non-Fuchs corneal dystrophies: insights from eight decades of histopathological and clinical data

Efficacy and safety of port delivery platform with ranibizumab (PDS) for diabetic macular oedema (Pagoda Randomised Clinical Trial)

Data and Temporal Risk Concerns of Semaglutide and NAION—Reply